» Articles » PMID: 23150186

Hereditary Nephrogenic Diabetes Insipidus in Japanese Patients: Analysis of 78 Families and Report of 22 New Mutations in AVPR2 and AQP2

Overview
Publisher Springer
Specialty Nephrology
Date 2012 Nov 15
PMID 23150186
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Familial form of nephrogenic diabetes insipidus (NDI) is a rare hereditary disease caused by arginine vasopressin type 2 receptor (AVPR2) or water channel aquaporin 2 (AQP2) gene mutations. It is speculated that 90% of NDI families carry disease-causing mutations in AVPR2 and 10% carry the mutations in AQP2; however, these percentages have not been supported by actual data. It is also unknown whether these percentages vary in different ethnic groups.

Methods: Gene mutation analyses were performed for 78 Japanese NDI families. All exons and intron-exon boundaries of the AVPR2 and AQP2 genes were directly sequenced.

Results: A total of 62 families (79%) carried disease-causing mutations in AVPR2, while nine families (12%) carried mutations in AQP2. We identified 22 novel putatively disease-causing mutations (19 in AVPR2 and 3 in AQP2). Regarding AVPR2, 52 disease-causing mutations were identified. Among them, missense mutations were most common (54%), followed by deletion mutations. In the 64 women who had monoallelic disease-causing AVPR2 mutations, 16 (25%) had NDI symptoms, including 4 complete NDI subjects. Regarding AQP2, 9 disease-causing mutations were identified in nine families. Two missense mutations and one deletion mutation showed a recessive inheritance, while one missense mutation and five small deletion mutations in the C-terminus of AQP2 showed a dominant inheritance.

Conclusions: Most Japanese NDI families carry disease-causing mutations in AVPR2 and 12% carry mutations in AQP2. A total of 22 novel putatively disease-causing mutations were identified. The relatively high occurrence of symptomatic carriers of AVPR2 mutations needs attention.

Citing Articles

Identification of a novel missense variant in the gene in a Japanese pedigree with familial neurohypophyseal diabetes insipidus.

Kojima D, Shibata M, Shikano H, Maruo Y, Fujii H Clin Pediatr Endocrinol. 2025; 34(1):77-82.

PMID: 39777129 PMC: 11701011. DOI: 10.1297/cpe.2024-0067.


Extreme hypernatremia after a laparoscopic hysterectomy and bilateral salpingo-oophorectomy: a case report and literature review.

Ding F, Nie X, Chen Y, Wang M, He Y Front Surg. 2024; 11:1462525.

PMID: 39474227 PMC: 11518838. DOI: 10.3389/fsurg.2024.1462525.


Genetic analysis of nephrogenic diabetes insipidus patients: A study on the Iranian population.

Ghasemi S, Mojbafan M, Talebi S, Hooman N, Hoseini R Mol Genet Genomic Med. 2024; 12(4):e2421.

PMID: 38622833 PMC: 11019120. DOI: 10.1002/mgg3.2421.


V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology.

Erdelyi L, Hunyady L, Balla A Front Endocrinol (Lausanne). 2023; 14:1173601.

PMID: 37293495 PMC: 10244717. DOI: 10.3389/fendo.2023.1173601.


Aquaporins in Diabetes Insipidus.

Lu H, He J Adv Exp Med Biol. 2023; 1398:267-279.

PMID: 36717500 DOI: 10.1007/978-981-19-7415-1_18.


References
1.
De Mattia F, Savelkoul P, Kamsteeg E, Konings I, van der Sluijs P, Mallmann R . Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus. J Am Soc Nephrol. 2005; 16(10):2872-80. DOI: 10.1681/ASN.2005010104. View

2.
Owada M, Kawamura M, Kimura Y, Fujiwara T, Uchida S, Sasaki S . Water intake and 24-hour blood pressure monitoring in a patient with nephrogenic diabetes insipidus caused by a novel mutation of the vasopressin V2R gene. Intern Med. 2002; 41(2):119-23. DOI: 10.2169/internalmedicine.41.119. View

3.
Fujimoto M, Imai K, Hirata K, Kashiwagi R, Morinishi Y, Kitazawa K . Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes. BMC Med Genet. 2008; 9:42. PMC: 2413213. DOI: 10.1186/1471-2350-9-42. View

4.
Spanakis E, Milord E, Gragnoli C . AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol. 2008; 217(3):605-17. DOI: 10.1002/jcp.21552. View

5.
Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A . Molecular cloning of the receptor for human antidiuretic hormone. Nature. 1992; 357(6376):333-5. DOI: 10.1038/357333a0. View